Volume 1, Issue 1 (August 2022)                   Health Science Monitor 2022, 1(1): 64-73 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kazempour Dizaji M, Marjani M, Tabarsi P, Varahram M, Zare A, Emamhadi M A, et al . Modeling the survival of patients with tuberculosis based on the model of artificial neural networks. Health Science Monitor 2022; 1 (1) :64-73
URL: http://hsm.umsu.ac.ir/article-1-48-en.html
Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (802 Views)
Background & Aims:  The development of treatment methods and increasing the survival of patients with tuberculosis (TB) has led to the complication of relationships between independent and dependent variables associated with this disease. Therefore, it is important to use new methods to model the TB process that can accurately estimate the current situation. This study aimed to model the survival of patients with tuberculosis based on the model of perceptron artificial multilayer neural network (MLP-ANN).
Materials and Methods: In this retrospective cohort study, the data was collected from 2366 TB patients who were treated in Dr. Masih Daneshvari Hospital in Tehran from 2005 to 2015. To model the predictive power of survival in TB patients, an MLP-ANN model consisting of three layers was applied.
Results: The results of this study showed that based on the MLP-ANN model, the correct predictive power of survival in TB patients is 88.4%. In this study, the variables of patients' age and family size as very effective variables also variables of patients’ gender, marital status, education, adverse drug effects, exposure to cigarette smoke, imprisonment, pulmonary tuberculosis, and AIDS as effective variables in predicting the survival of patients were diagnosed.
Conclusion: In the model of artificial neural networks, no restrictions are considered for the data structure and the type of relationship between variables. Therefore, these models with their flexibility and high accuracy can be one of the best methods for modeling health data.
Full-Text [PDF 381 kb]   (608 Downloads)    
Type of Study: Research | Subject: General
Received: 2022/07/12 | Accepted: 2022/08/14 | Published: 2022/08/20

References
1. Sargent DJ. Comparison of artificial neural networks with other statistical approaches: Results from medical data sets. Cancer. 2001 Apr 15;91(S8):1636-42. https://doi.org/10.1002/1097-0142(20010415)91:8+<1636::AID-CNCR1176>3.0.CO;2-D [DOI] [PMID]
2. Ahmed FE. Artificial neural networks for diagnosis and survival prediction in colon cancer. Mol Cancer. 2005 Dec;4(1):29. [DOI] [PMID] [PMCID]
3. Miller TL, Wilson FA, Pang JW, Beavers S, Hoger S, Sharnprapai S, Pagaoa M, Katz DJ, Weis SE. Mortality hazard and survival after tuberculosis treatment. American journal of public health. 2015 May;105(5):930-7. [DOI] [PMID] [PMCID]
4. Dizaji MK, Kazemnejad A, Tabarsi P, Zayeri F. Risk factors associated with survival of pulmonary tuberculosis. Iranian Journal of Public Health. 2018 Jul;47(7):980. [PMID] [PMCID]
5. Kazempour-Dizaji M, Kazemnejad A, Tabarsi P, Zayeri F. Estimation of Ten-Year survival of patients with pulmonary tuberculosis based on the competing risks model in Iran. Tanaffos. 2016;15(1):37. [PMID] [PMCID]
6. Kleinbaum D, Klein M. Survival Analysis: A self-learning text, 2005. New York, NY: Spring Science+ Business Media. 2011. [DOI]
7. Kleinbaum DG, Klein M. Evaluating the Proportional Hazards Assumption. In: Survival Analysis [Internet]. New York, NY: Springer New York; 2012 [cited 2022 Sep 4]. p. 161-200. (Statistics for Biology and Health). Available from: http://link.springer.com/10.1007/978-1-4419-6646-9_4 [DOI]
8. Collett D. Modelling survival data in medical research. CRC press; 2015 May 4. [DOI]
9. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer; 2003 Feb. [DOI]
10. Akl A, Ismail AM, Ghoneim M. Prediction of Graft Survival of Living-Donor Kidney Transplantation: Nomograms or Artificial Neural Networks? Transplantation. 2008 Nov 27;86(10):1401-6. [DOI] [PMID]
11. Chi CL, Street WN, Wolberg WH. Application of artificial neural network-based survival analysis on two breast cancer datasets. InAMIA annual symposium proceedings 2007 (Vol. 2007, p. 130). American Medical Informatics Association. [PMID] [PMCID]
12. LaFaro RJ, Pothula S, Kubal KP, Inchiosa ME, Pothula VM, Yuan SC, et al. Neural Network Prediction of ICU Length of Stay Following Cardiac Surgery Based on Pre-Incision Variables. PLoS ONE. 2015 Dec 28;10(12):e0145395. [DOI] [PMID] [PMCID]
13. Yegnanarayana B. Artificial neural networks. 2009: PHI Learning Pvt. [Google Books]
14. Glaziou P, Sismanidis C, Floyd K, Raviglione M. Global Epidemiology of Tuberculosis. Cold Spring Harbor Perspectives in Medicine. 2015 Feb 1;5(2):a017798-a017798. [DOI] [PMID] [PMCID]
15. Tabarsi P, Mohammadtaheri Z, Chitsaz E, Farokhzad B, Hadavand F, Gachkar L, et al. Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. Ann Thorac Med. 2010;5(1):43. [DOI] [PMID] [PMCID]
16. Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, et al. First-line antituberculosis drug resistance prevalence and its pattern among HIV-infected patients in the national referral tuberculosis centre, Iran. Int J STD AIDS. 2009 Aug;20(8):566-70. [DOI] [PMID]
17. Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, et al. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International Journal of Infectious Diseases. 2005 Nov;9(6):317-22. [DOI] [PMID]
18. Tabarsi P, Chitsaz E, Moradi A, Baghaei P, Farnia P, Marjani M, et al. Treatment outcome, mortality and their predictors among HIV-associated tuberculosis patients. Int J STD AIDS. 2012 Sep;23(9):e1-4. [DOI] [PMID] [PMCID]
19. Albuquerque M de FPM de, Batista J d'Arc L, Ximenes RA de A, Carvalho MS, Diniz GTN, Rodrigues LC. Risk factors associated with death in patients who initiate treatment for tuberculosis after two different follow-up periods. Rev bras epidemiol. 2009 Dec;12(4):513-22. [DOI]
20. Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, et al. Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil. The Brazilian Journal of Infectious Diseases. 2014 Sep;18(5):491-5. [DOI] [PMID] [PMCID]
21. Oursler KK, Moore RD, Bishai WR, Harrington SM, Pope DS, Chaisson RE. Survival of Patients with Pulmonary Tuberculosis: Clinical and Molecular Epidemiologic Factors. Clinical Infectious Diseases. 2002 Mar 15;34(6):752-9. [DOI] [PMID]
22. Leprosy A.K.S.O. Tuberculosis situation in Iran 2015, Infectious Diseases Management Center - Ministry of Health, Treatment and Medical Education. [URL]
23. Vasantha M, Gopi PG, Subramani R. Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India. Indian Journal of Tuberculosis. 2008;55(2):64-9. [Google Scholar]
24. Akessa GM, Tadesse M, Abebe G. Survival Analysis of Loss to Follow-Up Treatment among Tuberculosis Patients at Jimma University Specialized Hospital, Jimma, Southwest Ethiopia. International Journal of Statistical Mechanics. 2015 Dec 31;2015:1-7. [DOI]
25. Wu YC, Lo HY, Yang SL, Chou P. Factors correlated with tuberculosis reported after death. int j tuberc lung dis. 2014 Dec 1;18(12):1485-90. [DOI] [PMID]
26. Wu YC, Lo HY, Yang SL, Chu DC, Chou P. Comparing the Factors Correlated with Tuberculosis-Specific and Non-Tuberculosis-Specific Deaths in Different Age Groups among Tuberculosis-Related Deaths in Taiwan. Hozbor DF, editor. PLoS ONE. 2015 Mar 3;10(3):e0118929 [DOI] [PMID] [PMCID]
27. Farley JE, Ram M, Pan W, Waldman S, Cassell GH, Chaisson RE, et al. Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence. Goletti D, editor. PLoS ONE. 2011 Jul 22;6(7):e20436. [DOI] [PMID] [PMCID]
28. Kay JW, Titterington DM. Statistics and neural networks: advances at the interface. Oxford University Press on Demand; 1999. [Google Books]
29. Kwon YS, Kim YH, Song JU, Jeon K, Song J, Ryu YJ, et al. Risk Factors for Death during Pulmonary Tuberculosis Treatment in Korea: A Multicenter Retrospective Cohort Study. J Korean Med Sci. 2014;29(9):1226. [DOI] [PMID] [PMCID]
30. Warner B, Misra M. Understanding Neural Networks as Statistical Tools. The American Statistician. 1996 Nov;50(4):284-93. [DOI]
31. Tsai PF (Jennifer), Chen PC, Chen YY, Song HY, Lin HM, Lin FM, et al. Length of Hospital Stay Prediction at the Admission Stage for Cardiology Patients Using Artificial Neural Network. Journal of Healthcare Engineering. 2016;2016:1-11. [DOI] [PMID] [PMCID]
32. Organization, W.H., Tuberculosis Fact sheet N°104. 2016. [URL]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Health Science Monitor

Designed & Developed by : Yektaweb